Concepedia

Hirofumi Kusaka

HK

Statistics

Publications

73

Citations

5.4K

H-Index

36

Active since

1984

Affiliations

Kansai Medical University(Current)

Kitano Hospital

Kyoto University

Montefiore Medical Center

Osaka City General Hospital

Hirofumi Kusaka is an author at Kansai Medical University specializing in neurodegenerative diseases, neuroscience, and neurology.

ORCID

Publications per year

1984–2021

73

Publications

73

Mutations of optineurin in amyotrophic lateral sclerosis

Hirofumi Maruyama, Hiroyuki Morino, Hidefumi Ito et al. · Nature · 2010 · 1.3K citations

, , +10

Safety and efficacy of edaravone in well defined patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled trial

Koji Abe, Masashi Aoki, Shoji Tsuji et al. · The Lancet Neurology · 2017 · 925 citations

, , +11

FET proteins TAF15 and EWS are selective markers that distinguish FTLD with FUS pathology from amyotrophic lateral sclerosis with FUS mutations

Manuela Neumann, Eva Bentmann, Dorothee Dormann et al. · Brain · 2011 · 312 citations · Full text

, , +17

FUS pathology in basophilic inclusion body disease

David G. Muñoz, Manuela Neumann, Hirofumi Kusaka et al. · Acta Neuropathologica · 2009 · 248 citations · Full text

, , +9

Treatment with edaravone, initiated at symptom onset, slows motor decline and decreases SOD1 deposition in ALS mice

Hidefumi Ito, Hidefumi Ito, Reika Wate et al. · Experimental Neurology · 2008 · 200 citations

, , +17

1–5 of 73